Head-to-head · Cost-Efficiency Index
Novi vs WeightRx
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Novi
Shoppers drawn to the lowest flat headline price in this batch, if they're comfortable that dosing, coverage states, and pharmacy details aren't published anywhere on the site.
Visit NoviWeightRx
Cost-first shoppers who want the lowest published tirzepatide figure, if you are willing to complete intake before you can read the plan terms.
Visit WeightRxThe verdict
Novi and WeightRx tie on the Cost-Efficiency Index at 69/100, so neither wins outright on the numbers. For most shoppers we'd start with Novi (ranked #105, a hair above #109) — Shoppers drawn to the lowest flat headline price in this batch, if they're comfortable that dosing, coverage states, and pharmacy details aren't published anywhere on the site. But WeightRx is a genuine coin-flip alternative here.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Novi.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Novi | WeightRx |
|---|---|---|
| Cost-Efficiency Index | 69/100 | 69/100 |
| Semaglutide / mo | $99/mo (all doses, promotional rate, compounded) | $250/mo (compounded) |
| Tirzepatide / mo | $133/mo (all doses, promotional rate, compounded) | $83/mo (term not published, compounded) |
| Semaglutide / yr (modeled) | $1,188 | $3,000 |
| Tirzepatide / yr (modeled) | $1,596 | $996 |
| Coverage | Coverage not published | Coverage not published |
| Oral / sublingual | No | No |
| Brand-name access | Yes | Compounded only |
| Rank here | #105 | #109 |
Novi
69/100Where the value is
- Lowest advertised entry price in this entire batch for both drugs ($99 semaglutide / $133 tirzepatide)
- LegitScript certified, independently verifiable via the linked legitscript.com record
- States one flat price per dose with no separate visit fee and free shipping
The tradeoffs
- No published mg dose, supply duration, state-coverage list, named medical director, or named compounding pharmacy anywhere on the site or its help center — the least transparent operational disclosure of any company researched in this batch
- The advertised $99/$133 rate is displayed against a live countdown timer ('price increases in...') next to a claimed $299 original price, a scarcity tactic that makes it unclear whether this is a genuine standing rate or a recurring promotional one
WeightRx
69/100Where the value is
- The tirzepatide figure is published up front, and it is genuinely low against the field
- Both molecules are offered
- No membership charge is advertised alongside the medication rate
The tradeoffs
- The $83 monthly rate is advertised as '$83/month ($997/year)', which is twelve months of it — no month-to-month rate is separately published, and the terms state that a rate is locked for its full term
- Both product pages linked from the homepage return 404, so the plan terms cannot be read before intake
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.